ArriVent’s Nasdaq debut nabs $175M as signs indicate an opening IPO window

The latest stories trending on MedCity News.

Editor's Pick

Top Story ArriVent's Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window ArriVent BioPharma will apply the IPO cash toward furmonertinib, which the biotech says could offer advantages over Takeda Pharmaceutical and Johnson & Johnson drugs that address the same lung cancer target. It's the second biotech IPO of this week, following CG Oncology. Sponsored Content Achieving Operational Improvement Through Improved Awareness Levels Presented by Care Logistics Exceptional awareness levels help hospitals improve operational efficiency and can also help health systems increase capacity, improve access to care, achieve higher profitability and improve margins.  Learn more! Calling Startups and Accelerators Do you focus on oncology, cardiology, women's health, or burnout and operational efficiency? If so, then apply to pitch at INVEST 2024. There is no fee to apply and each track will feature six finalists. This is the perfect way to make new connections, find investors/get additional funding, and a chance to win $20K in advertising for your startup. Deadline to apply is February 29, 2024. Apply Today

Featured News

Pediatric Telehealth Startup Kismet Health Seeks to Improve Access to Care In response to emailed questions, Kismet Health Co-founders CEO Dr. Cierra Gromoff and COO Christie Sander talked about why they started the business. Pharma Just Increased the Price of Hundreds of Drugs. PBMs are Minimizing the Impact for Health Plans, Employers and Patients While pharmaceutical companies continue to raise list prices year-over-year, we work behind the scenes to fight the trend by driving competition, negotiating with drugmakers and incentivizing the use of less expensive medicines that deliver the same clinical value. \ Building a Digital Stockpiling Strategy One Shelf At A Time Shift from the stock shelf to the digital shelf and invest today in additive manufacturing technology so medical facilities can easily create repeatable, durable PPE on-demand printing to accelerate the process of securely printing equipment for medical professionals. Biosimilar Insulins Promise Patients New Choices, But Competition Is Still Lacking Insulin prices have long been a pain point for diabetics. The big three insulin manufacturers have cut prices across their product lineups, but potential competition from other biosimilar insulins is still in earlier stages of development. Why Startups Are Seeking Out Health Systems' VC Arms Health system VC arms appear to have a lot more to offer to startups than traditional VC funds. Startup founders say that the tech pilots they launch with their health system partners end up being more effective because they are more incentive-aligned. For health systems, investing in a startup allows them to have a hand in shaping the tools they will eventually deploy across their enterprises to solve issues like burnout, payment delays and excessive hospital readmissions.

Resources

How To Enable a Hyperpersonal Care Experience This on-demand webinar features expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe